CD22 and acute lymphoblastic leukemia: Considering the lymphoid origin of these malignant cells, immunophenotyping is essential for discriminating between ALL from T-cell (T-ALL; CD3, CD5, CD7, and TdT) (42) or B-cell lineages (B-ALL; CD19, CD22, CD10, and CD34) (43).